vs
Side-by-side financial comparison of Carter Bankshares, Inc. (CARE) and Evolus, Inc. (EOLS). Click either name above to swap in a different company.
Evolus, Inc. is the larger business by last-quarter revenue ($73.1M vs $39.8M, roughly 1.8× Carter Bankshares, Inc.). On growth, Carter Bankshares, Inc. posted the faster year-over-year revenue change (15.4% vs 6.7%). Over the past eight quarters, Carter Bankshares, Inc.'s revenue compounded faster (9.1% CAGR vs 4.6%).
Carter Bankshares, Inc. is a U.S. regional bank holding company operating Carter Bank & Trust, a community-focused financial institution. It offers a full range of retail and commercial banking products including deposit accounts, personal and business loans, and wealth management services, primarily serving consumers and small business clients across Virginia and North Carolina.
Evolus, Inc. is a medical aesthetics company focused on developing and commercializing non-surgical cosmetic treatment solutions. Its flagship product is a prescription neuromodulator designed to reduce moderate to severe glabellar frown lines, serving licensed aesthetic healthcare providers and consumers across North America, Europe, and key Asia-Pacific regional markets.
CARE vs EOLS — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $39.8M | $73.1M |
| Net Profit | — | $-10.7M |
| Gross Margin | — | 66.9% |
| Operating Margin | 27.8% | 23.8% |
| Net Margin | — | -14.6% |
| Revenue YoY | 15.4% | 6.7% |
| Net Profit YoY | — | — |
| EPS (diluted) | $0.38 | $-0.16 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $73.1M | ||
| Q4 25 | $39.8M | $90.3M | ||
| Q3 25 | $39.1M | $69.0M | ||
| Q2 25 | $37.3M | $69.4M | ||
| Q1 25 | $37.0M | $68.5M | ||
| Q4 24 | $34.5M | $78.9M | ||
| Q3 24 | $34.2M | $61.1M | ||
| Q2 24 | $33.6M | $66.9M |
| Q1 26 | — | $-10.7M | ||
| Q4 25 | — | $130.0K | ||
| Q3 25 | $5.4M | $-15.7M | ||
| Q2 25 | $8.5M | $-17.1M | ||
| Q1 25 | $9.0M | $-18.9M | ||
| Q4 24 | — | $-6.8M | ||
| Q3 24 | $5.6M | $-19.2M | ||
| Q2 24 | $4.8M | $-11.3M |
| Q1 26 | — | 66.9% | ||
| Q4 25 | — | 65.7% | ||
| Q3 25 | — | 66.5% | ||
| Q2 25 | — | 65.3% | ||
| Q1 25 | — | 68.1% | ||
| Q4 24 | — | 66.7% | ||
| Q3 24 | — | 68.9% | ||
| Q2 24 | — | 70.3% |
| Q1 26 | — | 23.8% | ||
| Q4 25 | 27.8% | 4.7% | ||
| Q3 25 | 18.3% | -16.7% | ||
| Q2 25 | 28.5% | -14.7% | ||
| Q1 25 | 30.1% | -22.1% | ||
| Q4 24 | 31.0% | -2.9% | ||
| Q3 24 | 20.5% | -25.3% | ||
| Q2 24 | 17.6% | -11.5% |
| Q1 26 | — | -14.6% | ||
| Q4 25 | — | 0.1% | ||
| Q3 25 | 13.9% | -22.8% | ||
| Q2 25 | 22.8% | -24.7% | ||
| Q1 25 | 24.2% | -27.6% | ||
| Q4 24 | — | -8.6% | ||
| Q3 24 | 16.4% | -31.4% | ||
| Q2 24 | 14.3% | -17.0% |
| Q1 26 | — | $-0.16 | ||
| Q4 25 | $0.38 | $0.01 | ||
| Q3 25 | $0.24 | $-0.24 | ||
| Q2 25 | $0.37 | $-0.27 | ||
| Q1 25 | $0.39 | $-0.30 | ||
| Q4 24 | $0.36 | $-0.11 | ||
| Q3 24 | $0.24 | $-0.30 | ||
| Q2 24 | $0.21 | $-0.18 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $49.8M |
| Total DebtLower is stronger | — | $156.4M |
| Stockholders' EquityBook value | $419.7M | — |
| Total Assets | $4.9B | $220.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $49.8M | ||
| Q4 25 | — | $53.8M | ||
| Q3 25 | — | $43.5M | ||
| Q2 25 | — | $61.7M | ||
| Q1 25 | — | $67.9M | ||
| Q4 24 | — | $87.0M | ||
| Q3 24 | — | $85.0M | ||
| Q2 24 | — | $93.7M |
| Q1 26 | — | $156.4M | ||
| Q4 25 | — | $146.1M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $121.8M | ||
| Q4 24 | — | $121.5M | ||
| Q3 24 | — | $121.2M | ||
| Q2 24 | — | $120.9M |
| Q1 26 | — | — | ||
| Q4 25 | $419.7M | $-23.1M | ||
| Q3 25 | $412.8M | $-28.8M | ||
| Q2 25 | $405.6M | $-18.7M | ||
| Q1 25 | $401.8M | $-6.6M | ||
| Q4 24 | $384.3M | $5.5M | ||
| Q3 24 | $386.8M | $5.9M | ||
| Q2 24 | $364.4M | $19.3M |
| Q1 26 | — | $220.6M | ||
| Q4 25 | $4.9B | $225.9M | ||
| Q3 25 | $4.8B | $219.0M | ||
| Q2 25 | $4.8B | $228.8M | ||
| Q1 25 | $4.7B | $213.4M | ||
| Q4 24 | $4.7B | $232.6M | ||
| Q3 24 | $4.6B | $229.6M | ||
| Q2 24 | $4.5B | $233.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 22.00× | ||
| Q3 24 | — | 20.58× | ||
| Q2 24 | — | 6.26× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $39.9M | — |
| Free Cash FlowOCF − Capex | $31.8M | — |
| FCF MarginFCF / Revenue | 79.9% | — |
| Capex IntensityCapex / Revenue | 20.2% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $54.6M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $39.9M | $12.8M | ||
| Q3 25 | $11.8M | $-14.7M | ||
| Q2 25 | $9.6M | $-24.8M | ||
| Q1 25 | $6.4M | $-15.6M | ||
| Q4 24 | $36.9M | $4.8M | ||
| Q3 24 | $10.3M | $-5.7M | ||
| Q2 24 | $-2.5M | $-6.5M |
| Q1 26 | — | — | ||
| Q4 25 | $31.8M | $11.3M | ||
| Q3 25 | $10.3M | $-15.6M | ||
| Q2 25 | $7.7M | $-25.5M | ||
| Q1 25 | $4.9M | $-16.0M | ||
| Q4 24 | $28.8M | $4.4M | ||
| Q3 24 | $8.4M | $-6.0M | ||
| Q2 24 | $-4.3M | $-6.9M |
| Q1 26 | — | — | ||
| Q4 25 | 79.9% | 12.6% | ||
| Q3 25 | 26.3% | -22.7% | ||
| Q2 25 | 20.6% | -36.7% | ||
| Q1 25 | 13.1% | -23.3% | ||
| Q4 24 | 83.5% | 5.5% | ||
| Q3 24 | 24.6% | -9.9% | ||
| Q2 24 | -12.7% | -10.4% |
| Q1 26 | — | — | ||
| Q4 25 | 20.2% | 1.6% | ||
| Q3 25 | 3.9% | 1.4% | ||
| Q2 25 | 5.1% | 1.0% | ||
| Q1 25 | 4.1% | 0.5% | ||
| Q4 24 | 23.6% | 0.6% | ||
| Q3 24 | 5.5% | 0.5% | ||
| Q2 24 | 5.4% | 0.7% |
| Q1 26 | — | — | ||
| Q4 25 | — | 98.67× | ||
| Q3 25 | 2.18× | — | ||
| Q2 25 | 1.13× | — | ||
| Q1 25 | 0.71× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.83× | — | ||
| Q2 24 | -0.51× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CARE
Segment breakdown not available.
EOLS
| Product revenue, net | $72.7M | 99% |
| Service revenue | $390.0K | 1% |
